BALA CYNWYD, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Penumbra, Inc. (NYSE – PEN)

Under the terms of the Merger Agreement, Penumbra will be acquired by Boston Scientific Corporation (NYSE: BSX) in a cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion. The investigation concerns whether the Penumbra Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/penumbra-inc-nyse-pen/,.

Calavo Growers, Inc. (Nasdaq – CVGW)

Under the terms of the Merger Agreement, Calavo Growers will be acquired by Mission Produce, Inc. (“Mission”) (Nasdaq - AVO) whereby Calavo stockholders will receive $27.00 per share comprised of $14.85 in cash and 0.9790 shares of Mission for each share of Calavo. The transaction values Calavo at a total enterprise value of approximately $430 million. Upon close, Mission shareholders are expected to own approximately 80.3% of the combined company and Calavo shareholders are expected to own approximately 19.7%. The investigation concerns whether the Calavo Growers Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/calavo-growers-inc-nasdaq-cvgw/.

Clearwater Analytics Holdings, Inc. (NYSE - CWAN)

Under the terms of the Merger Agreement, Clearwater Analytics will be acquired by Permira and Warburg Pincus-led Investor Group (the “Investor Group”) for $24.55 per share in cash in a transaction worth approximately $8.4 billion. The investigation concerns whether the Clearwater Analytics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company’s shareholders.

Additional information can be found at https://www.brodskysmith.com/cases/clearwater-analytics-holdings-inc-nyse-cwan/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.